Communication Equipment
Compare Stocks
5 / 10Stock Comparison
LTRX vs SIFY vs CSCO vs HCTI vs MSFT
Revenue, margins, valuation, and 5-year total return — side by side.
Telecommunications Services
Communication Equipment
Medical - Healthcare Information Services
Software - Infrastructure
LTRX vs SIFY vs CSCO vs HCTI vs MSFT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Communication Equipment | Telecommunications Services | Communication Equipment | Medical - Healthcare Information Services | Software - Infrastructure |
| Market Cap | $231M | $1.15B | $364.95B | $49K | $3.13T |
| Revenue (TTM) | $119M | $41.45B | $59.05B | $13M | $318.27B |
| Net Income (TTM) | $-7M | $-1.50B | $11.08B | $-6M | $125.22B |
| Gross Margin | 42.9% | 34.2% | 64.4% | 13.1% | 68.3% |
| Operating Margin | -5.4% | 5.2% | 23.0% | -45.2% | 46.8% |
| Forward P/E | 34.8x | — | 22.2x | — | 25.3x |
| Total Debt | $21M | $39.51B | $29.64B | $3M | $112.18B |
| Cash & Equiv. | $20M | $5.00B | $9.47B | $20K | $30.24B |
LTRX vs SIFY vs CSCO vs HCTI vs MSFT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Lantronix, Inc. (LTRX) | 100 | 60.1 | -39.9% |
| Sify Technologies L… (SIFY) | 100 | 74.3 | -25.7% |
| Cisco Systems, Inc. (CSCO) | 100 | 164.7 | +64.7% |
| Healthcare Triangle… (HCTI) | 100 | 0.0 | -100.0% |
| Microsoft Corporati… (MSFT) | 100 | 126.9 | +26.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LTRX vs SIFY vs CSCO vs HCTI vs MSFT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LTRX lags the leaders in this set but could rank higher in a more targeted comparison.
SIFY ranks third and is worth considering specifically for momentum.
- +264.2% vs HCTI's -99.9%
CSCO is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (22.2x vs 25.3x)
- 1.7% yield, 15-year raise streak, vs MSFT's 0.8%, (2 stocks pay no dividend)
Among these 5 stocks, HCTI doesn't own a clear edge in any measured category.
MSFT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 19 yrs, beta 0.89, yield 0.8%
- Rev growth 14.9%, EPS growth 15.6%, 3Y rev CAGR 12.4%
- 7.9% 10Y total return vs CSCO's 301.7%
- Lower volatility, beta 0.89, Low D/E 32.7%, current ratio 1.35x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.9% revenue growth vs HCTI's -64.8% | |
| Value | Lower P/E (22.2x vs 25.3x) | |
| Quality / Margins | 39.3% margin vs HCTI's -48.9% | |
| Stability / Safety | Beta 0.89 vs HCTI's 3.07 | |
| Dividends | 1.7% yield, 15-year raise streak, vs MSFT's 0.8%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +264.2% vs HCTI's -99.9% | |
| Efficiency (ROA) | 19.2% ROA vs HCTI's -60.0%, ROIC 24.9% vs -6.3% |
LTRX vs SIFY vs CSCO vs HCTI vs MSFT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
LTRX vs SIFY vs CSCO vs HCTI vs MSFT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 2 of 6 categories
SIFY leads 1 • LTRX leads 0 • CSCO leads 0 • HCTI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MSFT is the larger business by revenue, generating $318.3B annually — 24594.2x HCTI's $13M. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to HCTI's -48.9%. On growth, HCTI holds the edge at +44.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $119M | $41.4B | $59.1B | $13M | $318.3B |
| EBITDAEarnings before interest/tax | -$2M | $8.1B | $16.1B | -$6M | $192.6B |
| Net IncomeAfter-tax profit | -$7M | -$1.5B | $11.1B | -$6M | $125.2B |
| Free Cash FlowCash after capex | $8M | $0 | $12.8B | -$12M | $72.9B |
| Gross MarginGross profit ÷ Revenue | +42.9% | +34.2% | +64.4% | +13.1% | +68.3% |
| Operating MarginEBIT ÷ Revenue | -5.4% | +5.2% | +23.0% | -45.2% | +46.8% |
| Net MarginNet income ÷ Revenue | -5.5% | -3.6% | +18.8% | -48.9% | +39.3% |
| FCF MarginFCF ÷ Revenue | +7.1% | -9.2% | +21.8% | -94.7% | +22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.9% | +2.5% | +9.7% | +44.6% | +18.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +69.9% | -3.7% | +29.5% | -63.8% | +23.4% |
Valuation Metrics
Evenly matched — SIFY and CSCO each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 30.9x trailing earnings, MSFT trades at a 15% valuation discount to CSCO's 36.1x P/E. On an enterprise value basis, SIFY's 18.2x EV/EBITDA is more attractive than CSCO's 26.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $231M | $1.1B | $365.0B | $49,177 | $3.13T |
| Enterprise ValueMkt cap + debt − cash | $232M | $1.5B | $385.1B | $3M | $3.21T |
| Trailing P/EPrice ÷ TTM EPS | -20.10x | -119.57x | 36.14x | -0.01x | 30.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.81x | — | 22.18x | — | 25.34x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.64x |
| EV / EBITDAEnterprise value multiple | — | 18.19x | 26.34x | — | 19.72x |
| Price / SalesMarket cap ÷ Revenue | 1.88x | 2.73x | 6.44x | 0.00x | 11.10x |
| Price / BookPrice ÷ Book value/share | 3.03x | 4.65x | 7.87x | — | 9.15x |
| Price / FCFMarket cap ÷ FCF | 34.13x | — | 27.46x | — | 43.66x |
Profitability & Efficiency
MSFT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-113 for HCTI. LTRX carries lower financial leverage with a 0.28x debt-to-equity ratio, signaling a more conservative balance sheet compared to SIFY's 1.96x. On the Piotroski fundamental quality scale (0–9), CSCO scores 8/9 vs HCTI's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.8% | -7.7% | +23.2% | -112.9% | +33.1% |
| ROA (TTM)Return on assets | -5.4% | -1.8% | +9.0% | -60.0% | +19.2% |
| ROICReturn on invested capital | -10.5% | +3.3% | +13.0% | -6.3% | +24.9% |
| ROCEReturn on capital employed | -11.0% | +4.4% | +13.7% | — | +29.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 8 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.28x | 1.96x | 0.63x | — | 0.33x |
| Net DebtTotal debt minus cash | $1M | $34.5B | $20.2B | $3M | $81.9B |
| Cash & Equiv.Liquid assets | $20M | $5.0B | $9.5B | $20,000 | $30.2B |
| Total DebtShort + long-term debt | $21M | $39.5B | $29.6B | $3M | $112.2B |
| Interest CoverageEBIT ÷ Interest expense | -48.12x | 0.82x | 9.64x | -3.79x | 55.65x |
Total Returns (Dividends Reinvested)
SIFY leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSCO five years ago would be worth $18,718 today (with dividends reinvested), compared to $0 for HCTI. Over the past 12 months, SIFY leads with a +264.2% total return vs HCTI's -99.9%. The 3-year compound annual growth rate (CAGR) favors SIFY at 28.8% vs HCTI's -96.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.2% | +29.2% | +22.3% | -93.7% | -10.8% |
| 1-Year ReturnPast 12 months | +173.7% | +264.2% | +57.5% | -99.9% | -2.1% |
| 3-Year ReturnCumulative with dividends | +59.7% | +113.4% | +109.3% | -100.0% | +39.5% |
| 5-Year ReturnCumulative with dividends | +8.8% | -12.1% | +87.2% | -100.0% | +72.5% |
| 10-Year ReturnCumulative with dividends | +425.2% | +141.0% | +301.7% | -100.0% | +787.7% |
| CAGR (3Y)Annualised 3-year return | +16.9% | +28.8% | +27.9% | -96.0% | +11.7% |
Risk & Volatility
Evenly matched — CSCO and MSFT each lead in 1 of 2 comparable metrics.
Risk & Volatility
MSFT is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than HCTI's 3.07 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSCO currently trades 97.3% from its 52-week high vs HCTI's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.17x | 1.33x | 0.92x | 3.07x | 0.89x |
| 52-Week HighHighest price in past year | $8.24 | $17.85 | $94.72 | $7410.00 | $555.45 |
| 52-Week LowLowest price in past year | $2.03 | $4.15 | $59.07 | $0.29 | $356.28 |
| % of 52W HighCurrent price vs 52-week peak | +70.8% | +89.0% | +97.3% | +0.0% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 59.1 | 56.7 | 63.9 | 36.7 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 613K | 56K | 18.9M | 572K | 32.5M |
Analyst Outlook
Evenly matched — CSCO and MSFT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: LTRX as "Buy", SIFY as "Buy", CSCO as "Buy", MSFT as "Buy". Consensus price targets imply 51.5% upside for LTRX (target: $9) vs 4.7% for CSCO (target: $97). For income investors, CSCO offers the higher dividend yield at 1.75% vs MSFT's 0.77%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | — | Buy |
| Price TargetConsensus 12-month target | $8.83 | — | $96.50 | — | $551.75 |
| # AnalystsCovering analysts | 6 | 1 | 73 | — | 81 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | +1.7% | — | +0.8% |
| Dividend StreakConsecutive years of raises | — | 0 | 15 | — | 19 |
| Dividend / ShareAnnual DPS | — | $0.36 | $1.61 | — | $3.23 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +2.0% | 0.0% | +0.6% |
MSFT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SIFY leads in 1 (Total Returns). 3 tied.
LTRX vs SIFY vs CSCO vs HCTI vs MSFT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LTRX or SIFY or CSCO or HCTI or MSFT a better buy right now?
For growth investors, Microsoft Corporation (MSFT) is the stronger pick with 14.
9% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Microsoft Corporation (MSFT) offers the better valuation at 30. 9x trailing P/E (25. 3x forward), making it the more compelling value choice. Analysts rate Lantronix, Inc. (LTRX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LTRX or SIFY or CSCO or HCTI or MSFT?
On trailing P/E, Microsoft Corporation (MSFT) is the cheapest at 30.
9x versus Cisco Systems, Inc. at 36. 1x. On forward P/E, Cisco Systems, Inc. is actually cheaper at 22. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — LTRX or SIFY or CSCO or HCTI or MSFT?
Over the past 5 years, Cisco Systems, Inc.
(CSCO) delivered a total return of +87. 2%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: MSFT returned +787. 7% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LTRX or SIFY or CSCO or HCTI or MSFT?
By beta (market sensitivity over 5 years), Microsoft Corporation (MSFT) is the lower-risk stock at 0.
89β versus Healthcare Triangle, Inc. 's 3. 07β — meaning HCTI is approximately 247% more volatile than MSFT relative to the S&P 500. On balance sheet safety, Lantronix, Inc. (LTRX) carries a lower debt/equity ratio of 28% versus 196% for Sify Technologies Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — LTRX or SIFY or CSCO or HCTI or MSFT?
By revenue growth (latest reported year), Microsoft Corporation (MSFT) is pulling ahead at 14.
9% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Healthcare Triangle, Inc. grew EPS 45. 6% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, SIFY leads at 13. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LTRX or SIFY or CSCO or HCTI or MSFT?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — MSFT leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LTRX or SIFY or CSCO or HCTI or MSFT more undervalued right now?
On forward earnings alone, Cisco Systems, Inc.
(CSCO) trades at 22. 2x forward P/E versus 34. 8x for Lantronix, Inc. — 12. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LTRX: 51. 5% to $8. 83.
08Which pays a better dividend — LTRX or SIFY or CSCO or HCTI or MSFT?
In this comparison, CSCO (1.
7% yield), MSFT (0. 8% yield) pay a dividend. LTRX, SIFY, HCTI do not pay a meaningful dividend and should not be held primarily for income.
09Is LTRX or SIFY or CSCO or HCTI or MSFT better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
89), 0. 8% yield, +787. 7% 10Y return). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +787. 7%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LTRX and SIFY and CSCO and HCTI and MSFT?
These companies operate in different sectors (LTRX (Technology) and SIFY (Communication Services) and CSCO (Technology) and HCTI (Healthcare) and MSFT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
CSCO, MSFT pay a dividend while LTRX, SIFY, HCTI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.